Celldex Therapeutics reported $3.03M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
Amgen USD 56.2B 1.18B Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Celldex Therapeutics USD 3.03M 3.03M Jun/2025
Glaxosmithkline GBP 17.35B 368M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024